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ABSTRACT
Objective: This study analyzed 
acute respiratory failure caused by 
acute pulmonary edema, as well as 
chronic obstructive pulmonary disease 
exacerbation, that was treated with 
non-invasive mechanical ventilation to 
identify the factors that are associated 
with the success or failure non-invasive 
mechanical ventilation in urgent and 
emergency service.
Methods: This study was a 
prospective, descriptive and analytical 
study. We included patients of both 
genders aged ≥18 years who used non-
invasive mechanical ventilation due 
to acute respiratory failure that was 
secondary to acute pulmonary edema 
or chronic obstructive pulmonary 
disease exacerbation. Patients with 
acute respiratory failure that was 
secondary to pathologies other than 
acute pulmonary edema and chronic 
obstructive pulmonary disease or who 
presented with contraindications for 
the technique were excluded. Expiratory 
pressures between 5 and 8 cmH2O and 
inspiratory pressures between 10 and 
12 cmH2O were used. Supplemental 
oxygen maintained peripheral oxygen 
saturation at >90%. The primary 
outcome was endotracheal intubation.
Results: A total of 152 patients were 
included. The median non-invasive 
mechanical ventilation time was 6 hours 
(range 1 - 32 hours) for chronic obstructive 
pulmonary disease patients (n=60) and 
5 hours (range 2 - 32 hours) for acute 
pulmonary edema patients (n=92). Most 
(75.7%) patients progressed successfully. 
However, reduced APACHE II scores and 
lower peripheral oxygen saturation were 
observed. These results were statistically 
significant in patients who progressed 
to intubation (p<0.001). BiPAP (Bi-
level Positive Airway Pressure portable 
ventilator), as continuous positive airway 
pressure use increased the probability 
of endotracheal intubation 2.3 times 
(p=0.032). Patients with acute pulmonary 
edema and elevated GCS scores also 
increased the probability of success.
Conclusion: Respiratory frequency 
>25 rpm, higher APACHE II scores, 
BiPAP use and chronic obstructive 
pulmonary disease diagnosis were 
associated with endotracheal intubation. 
Higher GCS and SpO2 values were 
associated with NIV success. Non-
invasive mechanical ventilation 
can be used in emergency services 
in acute respiratory failure cases 
caused by acute pulmonary edema 
and chronic obstructive pulmonary 
disease exacerbation, but patients with 
variables related to a higher percentage 
of endotracheal intubation should be 
specially monitored.
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INTRODUCTION
Acute respiratory failure (ARF) is a clinical 
condition in which the respiratory system cannot 
maintain adequate blood pressure values of oxygen 
and carbon dioxide. The deterioration of pulmonary 
gas exchange is a common occurrence in urgent and 
emergency services.
The management of this clinical condition 
generates a dilemma between prompt endotracheal 
intubation (EI) or the implementation of non-invasive 
mechanical ventilation (NIV), which is an effective 
alternative because it reduces the need for EI and its 
related risks. NIV is an increasingly frequent and safe 
procedure.(1-6)
NIV is defined as the ventilatory support of positive 
pressure without the use of a tracheal prosthesis 
through the upper airway using interfaces.(1-9) The 
primary advantage of this method is the prevention 
of complications from invasive ventilation, such as 
the aspiration of gastric contents, oropharynx trauma, 
ventilator-associated pneumonia (VAP), tracheal 
stenosis and pneumothorax.(10)
The main indications for NIV are associated with 
chronic obstructive pulmonary disease (COPD) 
exacerbation and acute cardiogenic pulmonary edema 
(APE).(4,11-14) The main contraindications include 
a decreased level of consciousness, psychomotor 
agitation, hemodynamic instability, obstruction 
and trauma of the upper airway and undrained 
pneumothorax.(1,8)
The most discussed NIV methods include 
continuous positive airway pressure (CPAP), which 
uses a single pressure level during both phases of the 
respiratory cycle, and ventilation with two levels of 
pressure (BiPAP - bi-level positive airway pressure), 
which uses an inspiratory positive airway pressure 
(IPAP) and an expiratory positive airway pressure 
(EPAP).(1,8,9)
The nasal mask, oronasal mask and the total facial 
mask are the most commonly used interfaces. The 
chance of NIV success increases with the appropriate 
choice of modality and interface and a well-trained 
team.(1,8,10) A portion of urgent care (UC) services 
and intensive care units (ICU) do not rely on the 
NIV technique, due to a lack of equipment and 
professionals who are experienced with the method.(15) 
Patients should not be totally dependent on the NIV 
for survival, and they should be capable of assisting 
with the technique.(1,2,8,10)
The best predictors of NIV success relate to 
pH variation during the first hour of ventilation 
and the clinical improvement of the patient.(6,7,16,17) 
Another predictor is the analysis of disease severity, 
which is scored using the Acute Physiology and 
Chronic Health Evaluation II (APACHE II). 
Other factors, such as the level of understanding, 
advanced age, extensive pneumonia and adaptation 
and/or interface deficiency, must be considered in 
the success of NIV.(2,3,6,10,16,18-21)
Patients who do not respond to therapy and 
exhibit a decline in clinical and laboratory standards 
may require EI due to the failure of NIV technique 
or disease severity. EI is indicated in patients with a 
sudden drop in peripheral blood oxygen saturation 
(SpO2) after mask removal and who do not improve 
after 2 h of NIV.(2,10)
This study examined patients with ARF due to 
APE and COPD exacerbation who received NIV 
to identify the factors that are associated with the 
success or failure of this technique and its efficacy in 
an urgent and emergency reference service (UER) in a 
secondary/tertiary-level hospital.
METHODS
This study was a prospective, descriptive and 
analytical study that was approved by the College of 
Medical Sciences Ethics Committee - UNICAMP 
(#726/2010). The Ethics Committee authorized 
the study without patient consent requirements. 
We conducted the survey through the collection of 
database variables from a continuous databank and 
records in the UER unit at Hospital Estadual Sumaré 
from October 2007 to June 2010.
We included patients of both genders aged ≥ 18 
years who used NIV due to ARF secondary to APE or 
COPD exacerbation. Patients with insufficient data for 
analysis, ARF secondary to different pathologies and 
APE and COPD patients with NIV contraindications 
were excluded.
The motives for NIV indication, clinical diagnosis, 
age and the clinical signs of respiratory distress, 
including increased respiratory rate (RR), accessory 
muscle use, expiratory effort, intercostal retracting, 
nasal flaring and paradoxical breathing, were recorded. 
We also noted the SpO2 and calculated the APACHE 
II prognostic index.
The UER routine established the EPAP at 
approximately 5 to 8 cmH2O and the IPAP between 
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10 and 12 cmH2O, depending on the use of equipment 
with one or two pressure levels and according to 
the patient’s tolerance. The RR was maintained at 
<30 rpm (ideal for the patient’s tidal volume), and 
supplemental oxygen maintained the SpO2 >90. 
The choice of equipment sometimes depended on 
availability at the time of admission and the severity 
of the case. The duration and success or failure of NIV 
was recorded after equipment installation. Patients 
who exhibited clinical and gasometric improvement 
were continued on the same therapy. However, patients 
who exhibited a worsening of clinical symptoms or 
any contraindications for the technique received EI, 
which was the outcome variable.
Statistical analysis
We processed the data using the Statistical Package 
for Social Science software (SPSS) 16.0 (SPSS Inc., 
Chicago, IL, USA).
 We used the Mann-Whitney U test to compare 
the distribution of quantitative variables of two 
independent groups that were not normally distributed. 
These data are expressed as medians (min-max).
We used the χ2 or Fisher’s exact test to evaluate 
the association between dependent and independent 
qualitative variables when indicated. The crude odds 
ratio and its 95% confidence interval (95% CI) was 
determined using Epi-Info software, version 6.04d 
(CDC, USA). We used non-conditional logistic 
regression, Forward Stepwise Wald method, with a 
0.05 probability of inclusion and a 0.10 probability of 
exclusion in the model. Variables that exhibited a p<0.2 
in the prior bivariate analysis were included in the model. 
We adopted a 5% significance level in all cases.
RESULTS
The sample consisted of 152 patients, including 
76 females. A total of 92 (60.5%) patients presented 
with a diagnostic hypothesis of APE, and 60 (39.5%) 
patients presented with COPD. The median age of 
the APE group was 63.5 (30 - 93) years and 67.5 (29-
87) years in the COPD patients. The initial analysis 
of the APACHE II score revealed no statistically 
significance difference between the COPD and APE 
groups (p=0.399).
The median duration of NIV use was 6 (1 - 32) 
hours for COPD patients (n=60) and 5 (2 - 32) hours 
for APE patients. No statistically significant difference 
between NIV duration or the adopted mode was 
observed between groups (p=0.184 and p=0.817, 
respectively) (Table 1). The SpO2 of the COPD and 
APE groups at the time of hospitalization in the UER 
was similar (p=0.112). However, progression to EI 
was different between groups (p=0.001).






APACHE II 16 (7-27) 15 (5-29) 0.399
Age (years) 67.5 (29-87) 63.5 (30-93) 0.811
SpO2 (%) 82 (67-93) 87 (55-98) 0.112
NIV duration (hours) 6 (1-32) 5 (2-32) 0.184
NIV modality 0.817
CPAP 6 (2-32) 6 (1-32)
BiPAP 6 (1-30) 5 (1-31)
RR>25 44 (73.4) 71 (77.2) 0.590
Accessory muscle use 40 (66.6) 42 (45.6) 0.011
Expiratory effort 45 (75) 50 (54.3) 0.010
Intercostal retraction 18 (30) 37 (40.2) 0.200
Nasal flaring 1 (1.6) 6 (6.52) 0.246
Outcome 0.528
Death in the UER 1 (1.6) 5 (5.5)
Transfer 56 (93.4) 79 (85.9)
Hospital discharge 3 (5) 8 (8.6)
Intubation 19 (51.4) 18 (48.6) 0.089
COPD - chronic obstructive pulmonary disease; APE - acute pulmonary edema; NIV - 
non-invasive ventilation; RR - respiratory rate, UER - urgent and emergency reference 
unit. The results are expressed as a number (percentage) or median (min-max). Chi-
square, Mann-Whitney U or Fischer’s exact tests.
Signs of respiratory distress were analyzed at the 
time of hospitalization in the UER, including RR 
>25 rpm, accessory muscle use, expiratory effort, 
intercostal retraction and nasal flaring. The use of 
accessory muscles was present in 66.6% of patients in 
the COPD group, and expiratory effort was observed 
in 75% of COPD patients. The use of accessory 
muscles was observed in 45.6% of patients in the APE 
group, and expiratory effort was observed in 54.3% 
of APE patients (p=0.011 and p=0.010, respectively) 
(Table 1). The other variables were not statistically 
significant between groups.
Eleven (7.2%) of the 152 patients that were treated 
in the UER were discharged, 44 (28.9%) patients 
were sent to the ICU and 91 (59.9%) patients were 
admitted to the ward. A third of the patients died: 6 
patients in the UER and 43 patients in other sectors 
(ward or ICU). The relationships among diagnosis 
and death, progression to discharge or transfer were 
examined, and no statistical significance was observed 
(p=0.528).
Thirty-seven of the 152 patients progressed to 
intubation. Patients who were intubated initially 
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exhibited lower SpO2 values - 79 (55 - 90) % - 
compared to patients who improved with NIV use. 
The median SpO2 was 86 (66 - 98) % in these patients. 
A statistically significant difference (p<0.001) in 
the APACHE II score was observed. Patients who 
progressed to EI exhibited higher scores than did 
patients who did not require intubation (19.4 (8 - 29) 
and 15 (5 - 28), respectively) (Table 2).
Table 2 - Risk factors for endotracheal intubation





p value OR aj (95% CI)
Gender 0.345
Female 16 (43.3) 60 (52.2)
Male 21 (56.7) 55 (47.8)
APACHE II 19 (8-29) 15 (5-28) < 0.001
SpO2 (%) 79 (55-90) 86 (66-98) < 0.001
RR>25 32 (86.5) 83 (72.2) 0.078 5.37 (1.42 - 20.27)
Accessory muscle 
use
25 (67.6) 57 (49.6) 0.056
Expiratory effort 26 (70.3) 69 (60) 0.262
Intercostal retraction 17 (46) 38 (33) 0.155
Nasal flaring 2 (5.4) 5 (4.4) 0.678
NIV modality 0.032 3.33 (1.22 - 9.12)
BiPAP 15 (40.6) 26 (22.6)
CPAP 22 (59.4) 89 (77.4)
Diagnosis 0.089 0.37 (0.14 - 0.96)
COPD 19 (51.4) 41 (35.7)
APE 18 (48.6) 74 (64.3)
RR - respiratory rate; NIV - non-invasive ventilation; BiPAP - bi-level positive airway 
pressure; CPAP -continuous positive airway pressure; COPD - chronic obstructive 
pulmonary disease; APE - acute pulmonary edema. The results are expressed as a 
number (percentage) or median (min-max). Chi-square, Mann-Whitney U or Fischer’s 
exact tests. OR aj - adjusted Odds Ratio, 95 CI - 95% confidence interval (OR aj and CI 
relate to results after multivariate analysis).
No difference between COPD and APE was observed 
in the 37 patients who progressed to EI. The impact of 
gender, clinical signs and NIV type on EI outcome was 
investigated. Only NIV type exhibited a statistically 
significant difference (p=0.032). Fifteen (40.6%) of 
the 37 EI patients received BiPAP versus 22 patients 
(59.4%) who received NIV as CPAP (Table 2). BiPAP 
use increased the probability of EI occurrence 2.3 times 
compared to patients who used CPAP (p=0.032).
Table 2 describes the results of the multivariate 
logistic regression analysis. RR >25, NIV, clinical 
diagnosis, Glasgow coma scale (GCS), SpO2 and 
APACHE II scale remained in the model. Progression 
to EI was higher in patients with RR >25 (adjusted 
OR= 5.37, 95% CI=1.42-20.27), patients who 
received BiPAP (adjusted OR 3.33, 95% CI=1.22-
9.12) and patients with higher Apache II scores 
(adjusted OR= 1.16, 95% CI=1.04-1.28).
Progression to EI was 63% lower in APE patients 
(adjusted OR=0.37, 95% CI=0.14-0.96). Higher 
values of SpO2 GCS increased the probability of 
favorable NIV.
DISCUSSION
This study evaluated the predictive rates of success 
or failure of NIV in an urgent and emergency service 
to delineate the clinical and laboratory situations that 
favor the use of this procedure in specific patient 
populations.
This study evaluated EI-related factors in patients 
with APE and COPD exacerbation who received NIV 
in a UER and demonstrated that an RR >25, a higher 
APACHE II score and the use of BiPAP predicted EI. 
The predictors of successful NIV were ARF caused by 
APE and higher Glasgow coma scores (GCS) and SpO2.
NIV use can prevent EI and its complications, 
such as airway trauma and VAP, during ARF episode 
in patients with COPD and APE. NIV intervention 
reduces hospital costs because hospitalization time is 
reduced.(7,9,10,17-19,22)
A systematic review and meta-analysis by 
Lightowler et al.(20) demonstrated that NIV should 
be the first treatment choice in COPD patients, 
especially patients with serious disease exacerbation 
who exhibit respiratory acidosis (pH<7.35). These 
authors advocate the installation of NIV prior to the 
worsening of acidosis to avoid EI and reduce mortality. 
The use of positive pressure in APE patients promotes 
alveolar fluid redistribution and the recruitment of 
collapsed alveoli, which reduces dyspnea, normalizes 
metabolism and favors oxygenation.(1,8,13) CPAP and 
BiPAP are safe, and both of these techniques decrease 
the need for intubation. CPAP and BiPAP should be 
associated with conventional drug therapy in APE 
patients.(1,8,12,13,18)
Pladeck et al.(7) demonstrated that an average age 
that was identical to our study. In addition, 30 patients 
in this study with the same diagnosis also received 
NIV. However, NIV was used an average 19.9 hours 
in COPD patients and 7.8 hours in APE patients.
No statistical significances between diagnosis 
and death, hospital discharge or ward transfer were 
observed in this study. Tomii et al.(14) analyzed the 
impact of NIV initiation in patients with respiratory 
failure due to varying etiologies in emergency service 
and demonstrated that NIV reduced the need for 
transfer to the ICU. Plant et al.(19) suggested that NIV 
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use in patients with COPD exacerbation prevented 3 
to 9 ICU admissions/year.
This study demonstrated a rate of NIV success that 
was consistent with previous reports.(2-6) Schettino 
et al. demonstrated an NIV failure in 18% of APE 
patients and 24% of COPD patients.(23)
NIV failure in this study was associated with an 
RR >25 rpm, disease severity as demonstrated by a 
APACHE II high score, the BiPAP type of NIV and a 
diagnosis of COPD. However, higher GCS and SpO2 
values reduced the probability of EI. Confalonieri et 
al. demonstrated that the patients who presented an 
RR ≥30 rpm, GCS <11, APACHE II ≥29 and pH 
<7.25 at admission exhibited a >70% risk of NIV 
failure.(24) Shirakabe et al.(12) analyzed 343 patients 
with heart failure who received NIV and demonstrated 
that the lowest level of arterial blood pH predicted 
NIV failures. This research analyzed pH indirectly to 
calculate APACHE II. Hess(3) and Kaya et al.(2) also 
related high APACHE II scores to NIV failure. A 
prospective and multicenter study by Antonelli et al.(5) 
demonstrated that the risk of NIV failure was greater 
in patients with high disease severity scores, old age, 
the presence of acute respiratory distress syndrome 
(ARDS) or pneumonia and the absence of clinical 
improvement 1 hour after NIV treatment. Spada et 
al.(25) analyzed the SpO2 and demonstrated that greater 
SpO2 was associated with NIV success. These authors 
emphasized the utility of this predictor because it can 
be quickly and non-invasively acquired.
The use of accessory muscles and expiratory 
effort were more noticeable at admission in patients 
with respiratory failure due to APE or COPD 
exacerbation. Pladeck et al.(7) concluded that these 
signs or dyspnea were eligible criteria for NIV use 
in COPD and APE patients.
We also observed that NIV modality but not 
gender or clinical signs was related to EI. Patients who 
received NIV through BiPAP presented unfavorable 
progress, and these patients were 2.3 times more 
likely to require EI compared to patients who received 
CPAP. This result is probably due to the greater 
disease severity in the patients who received BiPAP 
because these patients exhibited median APACHE II 
scores of 16.
However, the largest and most recent multicenter 
controlled and randomized clinical study, which 
examined 1,069 patients who were admitted for 
respiratory failure due to APE in 26 different emergency 
services, demonstrated no relationship between NIV 
modality and EI outcome.(13) Nouira et al.(11) observed 
similar effects of BiPAP use compared to CPAP on EI 
outcomes. Nonetheless, BiPAP is associated with faster 
improvements in respiratory failure in APE patients.
This clinical study has several methodological 
limitations. This observational research was not 
random. A convenient and non-consecutive sample 
was analyzed because the respiratory failure in patients 
who were admitted in the emergency department 
arose from a variety of health problems, which may 
underlie the absence of criteria for the selection of EI 
and limits the comparisons between NIV modalities 
(BiPAP and CPAP).
CONCLUSION
The analysis of APE and COPD patients who received 
NIV in an urgent and emergency unit revealed that most 
of these patients progressed successfully. A multivariate 
analysis using logistic regression demonstrated that 
an FR >25, higher APACHE II scores, BiPAP use and 
a COPD diagnosis increased the probability of EI. 
Similarly, higher GCS and SpO2 values reduced the 
probability of unfavorable developments.
RESUMO
Objetivo: Analisar os casos de insuficiência respiratória 
aguda decorrente de edema agudo de pulmão e de agudiza-
ção da doença pulmonar obstrutiva crônica, submetidos à 
ventilação mecânica não invasiva, a fim de identificar fato-
res associados ao sucesso ou ao insucesso do método em um 
serviço de urgência e emergência. 
Métodos: Estudo descritivo e analítico prospectivo. Fo-
ram incluídos pacientes de ambos os gêneros, com idade 
≥18 anos, que utilizaram ventilação mecânica não invasiva 
devido ao quadro de insuficiência respiratória secundária a 
edema agudo de pulmão ou agudização da doença pulmo-
nar obstrutiva crônica. Foram excluídos os pacientes com 
insuficiência respiratória aguda secundária a patologias 
diferentes de edema agudo de pulmão e doença pulmonar 
obstrutiva crônica, ou que apresentavam contraindicação 
para a técnica. A rotina da instituição é utilizar a pressão 
expiratória entre 5 e 8 cmH2O, e a inspiratória entre 10 a 
12 cmH2O, além de suplementação de oxigênio para man-
ter a saturação periférica de oxigênio >90%. A variável “des-
fecho” considerada foi a intubação endotraqueal. 
Resultados: Foram incluídos 152 pacientes. A media-
na do tempo de ventilação mecânica não invasiva foi de 6 
(1 - 32) horas para os pacientes com doença pulmonar obs-
trutiva crônica (n=60) e de 5 (2 - 32) horas para os pacien-
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tes com edema agudo de pulmão (n=92); 75,7% evoluíram 
com sucesso. Foram observados pior escore de APACHE 
II e menor saturação periférica de oxigênio, de forma esta-
tisticamente significante, nos pacientes que evoluíram para 
intubação (p<0,001). O uso de BiPAP relacionou-se a 2,3 
vezes mais chance de ocorrência de intubação endotraqueal 
que o de CPAP (p=0,032). Entre os pacientes com diagnós-
tico de edema agudo de pulmão e com pontuação mais ele-
vada na ECG também apresentaram mais chance de sucesso
Conclusão: As variáveis associadas à intubação endotra-
queal foram frequência respiratória > 25rpm, maior valor de 
APACHE II, uso de BiPAP e diagnóstico de doença pulmonar 
obstrutiva crônica. Já maiores valores de ECG e SpO2 estão 
associados ao sucesso da ventilação mecânica não invasiva. A 
ventilação mecânica não invasiva pode ser utilizada em serviços 
de urgência/emergência para casos de insuficiência respiratória 
aguda decorrente de edema agudo de pulmão e exacerbação da 
doença pulmonar obstrutiva crônica, com cuidado especial na 
monitoração dos pacientes com variáveis relacionadas à maior 
porcentagem de intubação endotraqueal.
Descritores: Pressão positiva contínua nas vias aéreas; 
Edema pulmonar; Doença pulmonar obstrutiva crônica; In-
suficiência respiratória; Emergência
